Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Conference Abstracts
, 2025, 'CTP-02. A Phase 1 trial of Deflexifol™ in pediatric patients with relapsed or refractory brain tumors', in Neuro-Oncology, Oxford University Press (OUP), Vol. 27, pp. v145 - v145, http://dx.doi.org/10.1093/neuonc/noaf201.0574
, 2024, 'Abstract B009: Individualized-tumor-informed panel approach enables ultra-sensitive ctDNA-based minimal residue disease monitoring for high-risk pediatric cancers', in Clinical Cancer Research, American Association for Cancer Research (AACR), Vol. 30, pp. b009 - b009, http://dx.doi.org/10.1158/1557-3265.liqbiop24-b009
, 2024, 'Abstract A044 Enhanced disease detection using single cell RNAseq in children with brain cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. a044 - a044, http://dx.doi.org/10.1158/1538-7445.pediatric24-a044
, 2024, 'Abstract A045 Implementing ultra-sensitive, ctDNA-based liquid biopsy for disease monitoring in paediatric tumours', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. a045 - a045, http://dx.doi.org/10.1158/1538-7445.pediatric24-a045
, 2024, 'Abstract B003: Expanding therapeutic horizons: Unleashing the untapped potential of MEK inhibitor treatment in pediatric cancers', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. b003 - b003, http://dx.doi.org/10.1158/1538-7445.pediatric24-b003
, 2024, 'Abstract B012: Clinical utility of real-time comprehensive molecular profiling in childhood brain tumors', in Cancer Research, American Association for Cancer Research (AACR), Vol. 84, pp. b012 - b012, http://dx.doi.org/10.1158/1538-7445.pediatric24-b012
, 2024, 'NOVEL TRANSCRIPTS ASSOCIATE WITH SURVIVAL IN CHILDHOOD MEDULLOBLASTOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, PA, Philadelphia, Vol. 26, presented at International Symposium on Pediatric Neuro-Oncology (ISPNO), PA, Philadelphia, 29 June 2024 - 02 July 2024, http://dx.doi.org/10.1093/neuonc/noae064.513
, 2024, 'DIPG-76. PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES', in Neuro-Oncology, Oxford University Press (OUP), Vol. 26, http://dx.doi.org/10.1093/neuonc/noae064.129
, 2024, '438 (PB426): Precision-guided treatment improves outcomes for children with highrisk cancers', in European Journal of Cancer, Elsevier, Vol. 211, pp. 114946, http://dx.doi.org/10.1016/j.ejca.2024.114946
, 2021, 'Abstract 3044: The unexplored immune landscape of high-risk pediatric cancers', in Cancer Research, American Association for Cancer Research (AACR), Vol. 81, pp. 3044 - 3044, http://dx.doi.org/10.1158/1538-7445.am2021-3044
, 2021, 'The unexplored immune landscape of high-risk pediatric cancers.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, Vol. 81, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 10 April 2021 - 21 May 2021
, 2017, 'Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy', in BLOOD, AMER SOC HEMATOLOGY, GA, Atlanta, Vol. 130, presented at 59th Annual Meeting of the American-Society-of-Hematology (ASH), GA, Atlanta, 09 December 2017 - 12 December 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432419405157&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia', in Blood, American Society of Hematology, Vol. 128, pp. 1182, http://dx.doi.org/10.1182/blood.v128.22.1182.1182
, 2015, 'Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity', in Blood, American Society of Hematology, Vol. 126, pp. 4984, http://dx.doi.org/10.1182/blood.v126.23.4984.4984